Capital Analysts LLC’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1K Hold
170
﹤0.01% 1515
2025
Q4
$1K Hold
170
﹤0.01% 1454
2025
Q3
$2K Hold
170
﹤0.01% 1378
2025
Q2
$2K Buy
+170
New +$1.75K ﹤0.01% 1320
2025
Q1
Sell
-100
Closed -$1K 1414
2024
Q4
$1K Sell
100
-40
-29% -$652 ﹤0.01% 1272
2024
Q3
$3K Sell
140
-24
-15% -$497 ﹤0.01% 1184
2024
Q2
$3K Buy
164
+25
+18% +$497 ﹤0.01% 1087
2024
Q1
$3K Sell
139
-252
-64% -$4.32K ﹤0.01% 1029
2023
Q4
$5K Sell
391
-899
-70% -$12.2K ﹤0.01% 965
2023
Q3
$23K Buy
1,290
+22
+2% +$459 ﹤0.01% 747
2023
Q2
$26K Buy
1,268
+98
+8% +$2.13K ﹤0.01% 687
2023
Q1
$28K Sell
1,170
-8
-0.7% -$215 ﹤0.01% 672
2022
Q4
$33K Sell
1,178
-17
-1% -$435 ﹤0.01% 679
2022
Q3
$28K Sell
1,195
-7
-0.6% -$211 ﹤0.01% 665
2022
Q2
$41K Sell
1,202
-2,813
-70% -$98.5K ﹤0.01% 594
2022
Q1
$140K Sell
4,015
-873
-18% -$29.9K 0.01% 376
2021
Q4
$149K Sell
4,888
-421
-8% -$13.7K 0.01% 380
2021
Q3
$174K Sell
5,309
-394
-7% -$12.6K 0.01% 360
2021
Q2
$173K Buy
+5,703
New +$188K 0.01% 353

Other funds holding OGN

Capital Analysts LLC's OGN Position: Q1 2026 in Review

Capital Analysts LLC held its Organon & Co (OGN) position steady in Q1 2026 at 170 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1515.

Capital Analysts LLC first reported a position in OGN in Q2 2021 and has held it in 19 quarters since. The position peaked at $174K in Q3 2021. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Capital Analysts LLC held 170 shares of Organon & Co worth $1K as of Q1 2026.
  • Capital Analysts LLC left its Organon & Co share count unchanged in Q1 2026.
  • Organon & Co made up ﹤0.01% of Capital Analysts LLC's portfolio in Q1 2026, its #1515 holding.
  • Capital Analysts LLC first reported a position in Organon & Co in Q2 2021 and has held it in 19 quarters since.
  • Capital Analysts LLC's Organon & Co position peaked at $174K in Q3 2021.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Capital Analysts LLC's 13F filing for Q1 2026, filed 14 May 2026.